Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Summit Therapeutics Inc. - Common Stock (NQ: SMMT ) 18.21 -1.07 (-5.55%) Streaming Delayed Price Updated: 4:00 PM EST, Dec 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,712,963 Open 19.01 Bid (Size) 18.11 (1) Ask (Size) 18.25 (7) Prev. Close 19.28 Today's Range 17.98 - 19.30 52wk Range 2.100 - 33.89 Shares Outstanding 97,381,774 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Where Will Summit Therapeutics Be in 5 Years? December 20, 2024 Via The Motley Fool 3 Stocks That Could Turn $1,000 into $5,000 by 2030 December 20, 2024 Via The Motley Fool Performance YTD +589.77% +589.77% 1 Month -3.85% -3.85% 3 Month -12.81% -12.81% 6 Month +133.46% +133.46% 1 Year +543.46% +543.46% More News Read More 3 No-Brainer Biotech Stocks to Buy With $200 Right Now December 18, 2024 Via The Motley Fool 2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street December 15, 2024 Via The Motley Fool Investing $5,000 in Each of These 3 Stocks at the Start of 2024 Would Have Created a Portfolio Worth More Than $100,000 Today December 14, 2024 Via The Motley Fool Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) December 13, 2024 From Summit Therapeutics Inc. Via Business Wire How Is The Market Feeling About Summit Therapeutics? December 13, 2024 Via Benzinga Why Summit Therapeutics Stock Rocketed 6% Higher on Friday December 06, 2024 Via The Motley Fool Billionaire Ken Griffin Is Selling Palantir and Buying a Stock Wall Street Expects to Rocket 139% Higher December 02, 2024 Via The Motley Fool Warning: This Skyrocketing Stock Has a Hidden Risk November 30, 2024 Via The Motley Fool Summit Therapeutics to Present at Upcoming Investor Conferences November 26, 2024 From Summit Therapeutics Inc. Via Business Wire 3 Monster Stocks in the Making November 23, 2024 Via The Motley Fool Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) November 21, 2024 From Summit Therapeutics Inc. Via Business Wire Merck Spends Up To $3.3 Billion In An Insurance Policy Against Summit Therapeutics November 14, 2024 Via Investor's Business Daily BioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer Potential November 09, 2024 Via Benzinga MarketBeat Week in Review – 11/4 - 11/8 November 09, 2024 Via MarketBeat Topics Economy Government Exposures Interest Rates Political 2 Hot Biopharma Stocks to Buy and Hold for 5 Years November 08, 2024 Via The Motley Fool Why Summit Therapeutics Stock Was a Winner Today November 04, 2024 Via The Motley Fool Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo November 04, 2024 Via Benzinga Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer? November 04, 2024 Via MarketBeat Exposures Product Safety This Tencent Music Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday November 04, 2024 Via Benzinga 3 Magnificent Stocks Under $100 to Buy in November November 03, 2024 Via The Motley Fool 2 Dividend Stocks to Buy for a Lifetime of Passive Income November 02, 2024 Via The Motley Fool 3 Stocks That Have Generated 1,000% Returns in Just 2 Years October 31, 2024 Via The Motley Fool Summit Therapeutics Reports Operational Progress and Financial Results for the Third Quarter and Nine Months Ended September 30, 2024 October 30, 2024 From Summit Therapeutics Inc. Via Business Wire Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
